Aller au contenu principal
Profil bibliographique

Davide Paolo Porru

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées
180Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Sinusitis and nasal conditionsAllergic Rhinitis and SensitizationAsthma and respiratory diseasesRheumatoid Arthritis Research and TherapiesDrug-Induced Adverse Reactions

Les publications récentes

Accès ouvert 2024 article OpenAlex

Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A “Real-Life” Observational Study

Eugenio De Corso, Dario Antonio Mele, Angela Rizzi, Camilla Spanu et autres

BACKGROUND/OBJECTIVES: Benralizumab is a monoclonal antibody that targets the interleukin-5 receptor (IL-5Rα), leading to the rapid depletion of blood eosinophils. RCTs have demonstrated efficacy in patients with severe eosinophilic asthma (SEA). The aim of this study was to assess the efficacy of …

it (code pays fourni par la source)

11 citations Journal of Personalized Medicine
Accès ouvert 2024 article OpenAlex

Comparative real‐world outcomes of dupilumab versus endoscopic sinus surgery in the treatment of severe CRSwNP patients

Eugenio De Corso, Davide Paolo Porru, Marco Corbò, Claudio Montuori et autres

INTRODUCTION: Management of severe chronic rhinosinusitis with nasal polyps (CRSwNP) has changed significantly in recent years, with different treatments now available including biologics and endoscopic sinus surgery (ESS), although there are still few comparative studies. We aimed to compare 1-year outcomes of …

it (code pays fourni par la source)

23 citations Clinical Otolaryngology
Accès ouvert 2022 article OpenAlex

Proposal for a Structured Outpatient Clinic for Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps in the First Year of Treatment

Sara Torretta, Eugenio De Corso, Nicolò Nava, Francesca Fraccaroli et autres

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common disease of the nose and paranasal sinuses with important economic and sanitary burdens, as well as having a great impact on patients' quality of life. In this field, a new therapeutic approach for …

it, ca (code pays fourni par la source)

11 citations Journal of Personalized Medicine
Accès ouvert 2022 article OpenAlex

Sinonasal Biomarkers Defining Type 2-High and Type 2-Low Inflammation in Chronic Rhinosinusitis with Nasal Polyps

Eugenio De Corso, Silvia Baroni, Stefano Settimi, Maria Elisabetta Onori et autres

The complex pathophysiology of chronic rhinosinusitis with nasal polyps (CRSwNP) generates a spectrum of phenotypes with a wide variety of inflammatory states. We enrolled 44 very-likely-to-be type 2 CRSwNP patients in order to evaluate the load of inflammation and to analyze human …

it (code pays fourni par la source)

32 citations Journal of Personalized Medicine
Accès ouvert 2022 article OpenAlex

Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A “Real-Life” Observational Study in the First Year of Treatment

Eugenio De Corso, Stefano Settimi, Claudio Montuori, Marco Corbò et autres

The aim of this study was to evaluate the efficacy of dupilumab in the treatment of severe uncontrolled Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), with or without asthma as add-on therapy with intra-nasal corticosteroids in a real-life setting over the first year …

it (code pays fourni par la source)

85 citations Journal of Clinical Medicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.